Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions - PubMed (original) (raw)
Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions
T A Thanaraj et al. Nucleic Acids Res. 2001.
Abstract
It has been previously observed that the intrinsically weak variant GC donor sites, in order to be recognized by the U2-type spliceosome, possess strong consensus sequences maximized for base pair formation with U1 and U5/U6 snRNAs. However, variability in signal strength is a fundamental mechanism for splice site selection in alternative splicing. Here we report human alternative GC-AG introns (for the first time from any species), and show that while constitutive GC-AG introns do possess strong signals at their donor sites, a large subset of alternative GC-AG introns possess weak consensus sequences at their donor sites. Surprisingly, this subset of alternative isoforms shows strong consensus at acceptor exon positions 1 and 2. The improved consensus at the acceptor exon can facilitate a strong interaction with U5 snRNA, which tethers the two exons for ligation during the second step of splicing. Further, these isoforms nearly always possess alternative acceptor sites and exhibit particularly weak polypyrimidine tracts characteristic of AG-dependent introns. The acceptor exon nucleotides are part of the consensus required for the U2AF(35)-mediated recognition of AG in such introns. Such improved consensus at acceptor exons is not found in either normal or alternative GT-AG introns having weak donor sites or weak polypyrimidine tracts. The changes probably reflect mechanisms that allow GC-AG alternative intron isoforms to cope with two conflicting requirements, namely an apparent need for differential splice strength to direct the choice of alternative sites and a need for improved donor signals to compensate for the central mismatch base pair (C-A) in the RNA duplex of U1 snRNA and the pre-mRNA. The other important findings include (i) one in every twenty alternative introns is a GC-AG intron, and (ii) three of every five observed GC-AG introns are alternative isoforms.
Figures
Figure 1
Illustration of common subsequences, at the donor and acceptor sites, that allow for different interpretations of the gene–transcript alignment.
Figure 2
Sequence logos at splice sites from normal and alternative GC-AG intron isoforms. The ‘RNA structure logo’ program (42) was used to derive the logos.
Figure 3
Sequence logos at splice sites for the three categories of GT-AG normal intron isoforms. Categorization is in terms of donor site strength as assessed by our SPC program (see text). SPC Major introns are those in which the donor sites could be validated by a single major rule of SPC. SPC Minor donor sites could still be validated by SPC but not by the single major rule. SPC Negative donor sites could not be validated by any of the SPC rules.
Figure 4
Sequence logos at splice sites for the three categories of GT-AG alternative intron isoforms. Used are only those isoforms that use alternative donor and acceptor sites [corresponding to (Alt, Alt) in Table 1].
Figure 5
Sequence logos at splice sites for the three categories of GC-AG alternative intron isoforms. In some of the SPC Major introns, only the donor site is alternative. Almost all of the SPC Minor and SPC Negative introns use alternative donor and acceptor sites.
Figure 6
Interaction of the Loop 1 of U5 snRNA with regions from the 5′ and 3′ exons. Bases that occurred in ≥70% of the cases in a group are shown in upper case; those that occurred in 35–70% of cases are shown in lower case (see Table 4 for actual values). Watson–Crick base pairs are indicated by a vertical line; non-Watson–Crick base pairs are indicated by a center dot.
Similar articles
- The U1, U2 and U5 snRNAs crosslink to the 5' exon during yeast pre-mRNA splicing.
McGrail JC, O'Keefe RT. McGrail JC, et al. Nucleic Acids Res. 2008 Feb;36(3):814-25. doi: 10.1093/nar/gkm1098. Epub 2007 Dec 15. Nucleic Acids Res. 2008. PMID: 18084028 Free PMC article. - Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human.
Clark F, Thanaraj TA. Clark F, et al. Hum Mol Genet. 2002 Feb 15;11(4):451-64. doi: 10.1093/hmg/11.4.451. Hum Mol Genet. 2002. PMID: 11854178 - Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
Kováčová T, Souček P, Hujová P, Freiberger T, Grodecká L. Kováčová T, et al. Int J Mol Sci. 2020 Sep 8;21(18):6553. doi: 10.3390/ijms21186553. Int J Mol Sci. 2020. PMID: 32911621 Free PMC article. - Principles and correction of 5'-splice site selection.
Malard F, Mackereth CD, Campagne S. Malard F, et al. RNA Biol. 2022 Jan;19(1):943-960. doi: 10.1080/15476286.2022.2100971. RNA Biol. 2022. PMID: 35866748 Free PMC article. Review. - Evolution of the Early Spliceosomal Complex-From Constitutive to Regulated Splicing.
Borao S, Ayté J, Hümmer S. Borao S, et al. Int J Mol Sci. 2021 Nov 18;22(22):12444. doi: 10.3390/ijms222212444. Int J Mol Sci. 2021. PMID: 34830325 Free PMC article. Review.
Cited by
- GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies.
Benbarche S, Pineda JMB, Galvis LB, Biswas J, Liu B, Wang E, Zhang Q, Hogg SJ, Lyttle K, Dahi A, Lewis AM, Sarchi M, Rahman J, Fox N, Ai Y, Mehta S, Garippa R, Ortiz-Pacheco J, Li Z, Monetti M, Stanley RF, Doulatov S, Bradley RK, Abdel-Wahab O. Benbarche S, et al. Mol Cell. 2024 May 16;84(10):1886-1903.e10. doi: 10.1016/j.molcel.2024.04.006. Epub 2024 Apr 29. Mol Cell. 2024. PMID: 38688280 - Inefficient splicing of long non-coding RNAs is associated with higher transcript complexity in human and mouse.
Basu K, Dey A, Kiran M. Basu K, et al. RNA Biol. 2023 Jan;20(1):563-572. doi: 10.1080/15476286.2023.2242649. RNA Biol. 2023. PMID: 37543950 Free PMC article. - Counteracting the Common Shwachman-Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing.
Peretto L, Tonetto E, Maestri I, Bezzerri V, Valli R, Cipolli M, Pinotti M, Balestra D. Peretto L, et al. Int J Mol Sci. 2023 Feb 16;24(4):4024. doi: 10.3390/ijms24044024. Int J Mol Sci. 2023. PMID: 36835434 Free PMC article. - Molecular characterization of genomic breakpoints of ALK rearrangements in non-small cell lung cancer.
Wang Z, Han Y, Tao H, Xu M, Liu Z, Zhu J, Li W, Ma J, Liu Z, Wang W, Ma T. Wang Z, et al. Mol Oncol. 2023 May;17(5):765-778. doi: 10.1002/1878-0261.13348. Epub 2022 Dec 13. Mol Oncol. 2023. PMID: 36423218 Free PMC article. - Splicing Analysis of 16 PALB2 ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants.
Valenzuela-Palomo A, Sanoguera-Miralles L, Bueno-Martínez E, Esteban-Sánchez A, Llinares-Burguet I, García-Álvarez A, Pérez-Segura P, Gómez-Barrero S, de la Hoya M, Velasco-Sampedro EA. Valenzuela-Palomo A, et al. Cancers (Basel). 2022 Sep 19;14(18):4541. doi: 10.3390/cancers14184541. Cancers (Basel). 2022. PMID: 36139699 Free PMC article.
References
- Burge C.B., Tuschl,T. and Sharp,P.A. (1999) Splicing of precursors to mRNAs by the spliceosomes. In Gesteland,R.F., Cech,T.R. and Atkins,J.F. (eds), The RNA World—The Nature Of Modern RNA Suggests a Prebiotic RNA. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 525–560.
- Madhani H.D. and Guthrie,C. (1994) Dynamic RNA–RNA interactions in the spliceosome. Annu. Rev. Genet., 28, 1–26. - PubMed
- Query C.C., Moore,M.J. and Sharp,P.A. (1994) Branch nucleophile selection in pre-mRNA splicing: evidence for the bulged duplex model. Genes Dev., 8, 587–597. - PubMed
- Valcarcel J., Gaur,R.K., Singh,R. and Green,M.R. (1996) Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA. Science, 273, 1706–1709. - PubMed
- Kramer A. (1996) The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem., 65, 367–409. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous